Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
azficel-T (Laviv) (1 trial)
Epidermolysis Bullosa (Phase 1)
Trials (1 total)
Trial APIs (1 total)